Trials / Completed
CompletedNCT03068494
Korean Coronary Bifurcation Stenting (COBIS) Registry III
Multicenter, Retrospective Korean Coronary Bifurcation Stenting (COBIS) Registry III
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,648 (actual)
- Sponsor
- Samsung Medical Center · Academic / Other
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
The COBIS III registry is a multi-center, real-world registry of 2nd generation drug-eluting stenting in coronary bifurcation lesions in South Korea. From 21 major coronary intervention centers in Korea, a total of 3,000 patients (anticipated) will be enrolled in this database between January 2010 and December 2014. The aim of the study was to investigate long-term clinical results and predictors of adverse outcomes after percutaneous coronary intervention with 2nd generation drug-eluting stents for coronary bifurcation lesions in South Korea.
Conditions
Timeline
- Start date
- 2017-02-28
- Primary completion
- 2018-12-29
- Completion
- 2018-12-29
- First posted
- 2017-03-01
- Last updated
- 2019-05-08
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT03068494. Inclusion in this directory is not an endorsement.